Private company

Invus Global Management, LLC

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Invus Global Management, LLC sits at the top of its group. 31 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Invus Global Management, LLC DE
- Abivax S.A. Stake · I0
- Agenus Stake · Lexington, Massachusetts, United States
- Bicara Therapeutics Inc. Stake · Boston, Massachusetts
- Bicycle Therapeutics (United Kingdom) Stake · Cambridge, United Kingdom
- CRESCENT BIOPHARMA, INC. Stake · Waltham, Massachusetts
- DBV Technologies Stake · Chatillon, France
- Eloxx Pharmaceuticals, Inc. Stake · Bridgewater, New Jersey, United States
- enGene Therapeutics Inc. Stake · Z4
- Gossamer Bio, Inc. Stake · San Diego, California, United States
- Hemab Therapeutics Holdings, Inc. Stake · Cambridge, Massachusetts
- HOOKIPA Pharma Inc. Stake · New York, New York
- IGM Biosciences, Inc. Stake · Mountain View, California, United States
- Inventiva S.A. Stake · I0
- Kalaris Therapeutics, Inc. Stake · Berkeley Heights, New Jersey
- Lexicon Pharmaceuticals Stake · The Woodlands
- Nanobiotix S.A. Stake · I0
- Neumora Therapeutics, Inc. Stake · Watertown, Massachusetts
- Olema Pharmaceuticals, Inc. Stake · San Francisco, California
- Rani Therapeutics Holdings, Inc. Stake · San Jose, California
- Rezolute, Inc. Stake · Redwood City, California, United States
- Scholar Rock Holding Corp Stake · Cambridge, Massachusetts, United States
- Seer, Inc Stake · Redwood City
- Silence Therapeutics Stake · London, United Kingdom
- Solid Biosciences Inc. Stake · Charlestown, Massachusetts
- Syros Pharmaceuticals, Inc. Stake · Cambridge, Massachusetts, United States
- and 5 more

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (30 companies). Each entity in the chart links to its source.

Stakes it holds

Invus Global Management, LLC has told the SEC it owns more than 5% of 30 companies, latest first (Schedules 13D and 13G).

Yarrow Bioscience, Inc.SCHEDULE 13G Sep 17, 2026²
Abivax S.A.SCHEDULE 13G/A Apr 11, 2025 to Aug 13, 2026³
Nanobiotix S.A.SCHEDULE 13G/A Apr 17, 2025 to Aug 13, 2026⁴
Scholar Rock Holding CorpSCHEDULE 13G/A Jul 29, 2024 to Aug 13, 2026⁵
Silence TherapeuticsSCHEDULE 13G/A Aug 2, 2024 to Aug 13, 2026⁶
enGene Therapeutics Inc.SCHEDULE 13G/A Jan 27, 2026 to Aug 13, 2026⁷
Hemab Therapeutics Holdings, Inc.SCHEDULE 13G Aug 7, 2026⁸
AgenusSCHEDULE 13G Jul 17, 2026⁹
Eloxx Pharmaceuticals, Inc.SCHEDULE 13G Jun 15, 2026¹⁰
Lexicon PharmaceuticalsSCHEDULE 13D/A Feb 2, 2026 to May 8, 2026¹¹
DBV TechnologiesSCHEDULE 13G/A Oct 14, 2025 to May 5, 2026¹²
Solid Biosciences Inc.SCHEDULE 13G/A Aug 2, 2024 to May 5, 2026¹³
Bicycle Therapeutics (United Kingdom)SCHEDULE 13G/A Mar 3, 2026 to May 4, 2026¹⁴
Neumora Therapeutics, Inc.SCHEDULE 13G/A Feb 19, 2026 to May 4, 2026¹⁵
Seer, IncSCHEDULE 13G/A Aug 2, 2024 to May 4, 2026¹⁶
TENAX THERAPEUTICS, INC.SCHEDULE 13G/A Oct 2, 2025 to May 4, 2026¹⁷
Tango Therapeutics (United States)SCHEDULE 13G/A Sep 22, 2025 to May 4, 2026¹⁸
Olema Pharmaceuticals, Inc.SCHEDULE 13G Mar 20, 2026¹⁹
Rezolute, Inc.SCHEDULE 13G/A Sep 22, 2025 to Feb 13, 2026²⁰
vTv Therapeutics Inc.SCHEDULE 13G/A Sep 8, 2025 to Nov 12, 2025²¹
Rani Therapeutics Holdings, Inc.SCHEDULE 13G Oct 23, 2025²²
Bicara Therapeutics Inc.SCHEDULE 13G/A Sep 26, 2024 to Jul 31, 2025²³
Inventiva S.A.SCHEDULE 13G/A Mar 31, 2025 to Jul 31, 2025²⁴
Kalaris Therapeutics, Inc.SCHEDULE 13G/A Aug 2, 2024 to Jul 29, 2025²⁵
Gossamer Bio, Inc.SCHEDULE 13G/A Aug 2, 2024 to Feb 12, 2025²⁶
Syros Pharmaceuticals, Inc.SCHEDULE 13G/A Aug 2, 2024 to Feb 12, 2025²⁷
Vigil Neuroscience, Inc.SCHEDULE 13G/A Aug 12, 2024 to Feb 12, 2025²⁸
CRESCENT BIOPHARMA, INC.SC 13G/A Jul 29, 2024 to Nov 12, 2024²⁹
HOOKIPA Pharma Inc.SC 13G/A Aug 2, 2024³⁰
IGM Biosciences, Inc.SC 13G/A Aug 2, 2024³¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInvus Global Management, LLC filings on SEC EDGAR
2
SEC EDGARInvus Global Management, LLC SCHEDULE 13G on Yarrow Bioscience, Inc.
3
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Abivax S.A.
4
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Nanobiotix S.A.
5
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Scholar Rock Holding Corp
6
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Silence Therapeutics
7
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on enGene Therapeutics Inc.
8
SEC EDGARInvus Global Management, LLC SCHEDULE 13G on Hemab Therapeutics Holdings, Inc.
9
SEC EDGARInvus Global Management, LLC SCHEDULE 13G on Agenus
10
SEC EDGARInvus Global Management, LLC SCHEDULE 13G on Eloxx Pharmaceuticals, Inc.
11
SEC EDGARInvus Global Management, LLC SCHEDULE 13D/A on Lexicon Pharmaceuticals
12
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on DBV Technologies
13
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Solid Biosciences Inc.
14
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Bicycle Therapeutics (United Kingdom)
15
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Neumora Therapeutics, Inc.
16
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Seer, Inc
17
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on TENAX THERAPEUTICS, INC.
18
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Tango Therapeutics (United States)
19
SEC EDGARInvus Global Management, LLC SCHEDULE 13G on Olema Pharmaceuticals, Inc.
20
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Rezolute, Inc.
21
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on vTv Therapeutics Inc.
22
SEC EDGARInvus Global Management, LLC SCHEDULE 13G on Rani Therapeutics Holdings, Inc.
23
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Bicara Therapeutics Inc.
24
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Inventiva S.A.
25
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Kalaris Therapeutics, Inc.
26
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Gossamer Bio, Inc.
27
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Syros Pharmaceuticals, Inc.
28
SEC EDGARInvus Global Management, LLC SCHEDULE 13G/A on Vigil Neuroscience, Inc.
29
SEC EDGARInvus Global Management, LLC SC 13G/A on CRESCENT BIOPHARMA, INC.
30
SEC EDGARInvus Global Management, LLC SC 13G/A on HOOKIPA Pharma Inc.
31
SEC EDGARInvus Global Management, LLC SC 13G/A on IGM Biosciences, Inc.